Stay updated on T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial
Sign up to get notified when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.

Latest updates to the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page
- Check4 days agoChange DetectedA new revision entry v3.5.3 was added to the Record History. The previous revision v3.5.2 was removed from the list to reflect the latest changes to the study record.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedVersion 44 adds Contacts/Locations, Study Design, and Study Status and updates the revision to v3.5.2; the previous revision v3.5.0 was removed on 2025-11-13.SummaryDifference0.4%

- Check25 days agoNo Change Detected
- Check40 days agoChange DetectedThe page now shows the latest revision as v3.5.0, replacing the previous v3.4.3. This updates the revision indicator without altering study data.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed in the record history.SummaryDifference0.1%

- Check82 days agoChange DetectedThe history shows an added Revision: v3.4.2 and deletions of a funding notice and Revision: v3.4.1; these are administrative site maintenance changes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check90 days agoChange DetectedAdded a government funding lapse notice and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the T-DXd and Immunotherapy in HER2+ NSCLC Clinical Trial page.